In the Boardroom
Refine Search
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Pharmaceutical
Japanese pharma major Astellas Pharma is making leadership changes affecting its operations in the Americas. 24 July 2018
Pharmaceutical
Germany’s Merck KGaA has hired Dr Maria Rivas as senior vice president, head of global medical affairs. 17 July 2018
Pharmaceutical
Having recently acquired the oncology business of Shire for $2.4 billion, leading independent French drugmaker Servier has now also acquired a senior executive of the company. 17 July 2018
Pharmaceutical
A small Swedish pharmaceutical company has taken another step towards being the first company in the world to launch a targeted treatment for premenstrual dysphoric disorder (PMDD) - the most debilitating form of premenstrual syndrome (PMS). 9 July 2018
Pharmaceutical
The UK’s leading pharmaceutical trade body, the Association of the British Pharmaceutical Industry (ABPI), has appointed Pfizer UK’s managing director Erik Nordkamp as president. 6 July 2018
Pharmaceutical
Danish CNS specialist Lundbeck has appointed Dr Deborah Dunsire as new president and CEO of Lundbeck. Dr Dunsire will take up her new position on September 1, 2018. 2 July 2018
Pharmaceutical
In a major restructuring, privately-held Switzerland-based healthcare company Roivant Sciences has created two new business units, Roivant Pharma and Roivant Health, to focus its efforts on accelerating the launch of new innovative healthcare companies, including ‘Vants’ oriented around earlier-stage scientific platforms. 28 June 2018
Pharmaceutical
US health care giant Johnson & Johnson has announced the appointment of a number of senior leaders to the company's executive committee. 25 June 2018
Pharmaceutical
Roche today announced that Sophie Kornowski-Bonnet, head of Roche Partnering and member of the enlarged corporate executive committee (CEC) since 2012, has accepted a new opportunity and will be leaving the company effective July 31, 2018. 22 June 2018
Pharmaceutical
French pharma major Sanofi has appointed Jean-Baptiste Chasseloup de Chatillon as executive vice president, chief financial officer (CFO) and member of the executive committee, effective October 1, 2018. 19 June 2018
Pharmaceutical
French independent pharma company Servier today announced the appointments of Christian Schubert and Rekha Paleyanda as directors of Servier BioInnovation along with the opening of the Servier BioInnovation office in Cambridge, Massachusetts. 7 June 2018
Pharmaceutical
Privately-held dermatology specialist LEO Pharma today announced that Dr Christian Antoni has been appointed as senior vice president for global development at the Danish firm as of June 1, 2018. 29 May 2018
Pharmaceutical
US drugmaker Eli Lilly is looking for a new head in one of its key therapy areas after the current incumbent announced her retirement. 24 May 2018
Pharmaceutical
UK-based drugmaker GlaxoSmithKline has announced that its chief financial officer Simon Dingemans is to retire. 10 May 2018
Pharmaceutical
French independent pharma company Pierre Fabre has named Eric Ducournau as its new chief executive, taking over from Bertrand Parmentier who has announced his retirement. 7 May 2018
Pharmaceutical
US pharma major Eli Lilly today announced that Leena Gandhi, a prestigious thoracic oncologist with a focus on immunotherapy and early drug development, will join Lilly Oncology on June 25, 2018 to lead immuno-oncology medical development. 2 May 2018
Pharmaceutical
Grünenthal has announced that Philip Just Larsen is to join the company chief scientific officer (CSO) and member of the corporate executive board. 30 April 2018
Pharmaceutical
The British and Irish arm of Japanese pharma titan Takeda has announced the promotion of Jon Neal to the role of managing director. 27 April 2018
Pharmaceutical
Danish specialty pharma company Xellia Pharmaceuticals has named the leader of its oncoming assault on the US market. 23 April 2018
Pharmaceutical
A month after US healthcare giant Johnson & Johnson announced that its chief financial officer (CFO) Dominic Caruso was to retire after 12 years in the role and Takeda's finance boss left his job with the Japanese firm, France’s biggest pharma company has said that it is losing its long-standing CFO. 19 April 2018
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze